Johnson & Johnson (JNJ) Shares Sold by Global X Management Co. LLC

Global X Management Co. LLC lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 19.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,187 shares of the company’s stock after selling 759 shares during the quarter. Global X Management Co. LLC’s holdings in Johnson & Johnson were worth $422,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Pioneer Investment Management Inc. increased its stake in Johnson & Johnson by 2.7% during the 2nd quarter. Pioneer Investment Management Inc. now owns 2,269,192 shares of the company’s stock valued at $300,192,000 after purchasing an additional 58,785 shares in the last quarter. HL Financial Services LLC increased its stake in Johnson & Johnson by 0.7% during the 2nd quarter. HL Financial Services LLC now owns 1,575,527 shares of the company’s stock valued at $208,427,000 after purchasing an additional 11,100 shares in the last quarter. Barrett Asset Management LLC increased its stake in Johnson & Johnson by 1.4% during the 2nd quarter. Barrett Asset Management LLC now owns 281,759 shares of the company’s stock valued at $37,274,000 after purchasing an additional 3,885 shares in the last quarter. MV Capital Management Inc. increased its stake in Johnson & Johnson by 3.9% during the 2nd quarter. MV Capital Management Inc. now owns 5,464 shares of the company’s stock valued at $723,000 after purchasing an additional 207 shares in the last quarter. Finally, Financial Advisory Service Inc. increased its stake in Johnson & Johnson by 0.9% during the 2nd quarter. Financial Advisory Service Inc. now owns 14,971 shares of the company’s stock valued at $1,981,000 after purchasing an additional 131 shares in the last quarter. Institutional investors and hedge funds own 65.93% of the company’s stock.

A number of analysts have commented on the stock. Citigroup Inc. boosted their price target on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a research note on Monday, October 23rd. Vetr upgraded shares of Johnson & Johnson from a “sell” rating to a “hold” rating and set a $137.71 price target for the company in a research note on Monday, October 30th. Leerink Swann restated an “outperform” rating and set a $165.00 price target (up previously from $150.00) on shares of Johnson & Johnson in a research note on Wednesday, October 18th. Royal Bank Of Canada boosted their price target on shares of Johnson & Johnson from $144.00 to $147.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Finally, Stifel Nicolaus boosted their price target on shares of Johnson & Johnson from $140.00 to $142.00 and gave the company a “hold” rating in a research note on Wednesday, October 18th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $143.70.

Johnson & Johnson (NYSE:JNJ) opened at $138.00 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36. The firm has a market cap of $370,739.75, a PE ratio of 19.33, a P/E/G ratio of 2.80 and a beta of 0.82. Johnson & Johnson has a fifty-two week low of $109.32 and a fifty-two week high of $144.35.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.80 by $0.10. The company had revenue of $19.65 billion for the quarter, compared to the consensus estimate of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.68 EPS. analysts predict that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Tuesday, November 28th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date is Monday, November 27th. Johnson & Johnson’s dividend payout ratio is currently 58.33%.

ILLEGAL ACTIVITY WARNING: “Johnson & Johnson (JNJ) Shares Sold by Global X Management Co. LLC” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://ledgergazette.com/2017/11/19/johnson-johnson-jnj-shares-sold-by-global-x-management-co-llc.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply